Health testing has never been faster, easier, and more personalized with Oxy-Gen Laboratory, click here to view our genetic testing menu.
Using precision medicine and innovative techniques to help healthcare professionals improve the treatment and outcomes of their patients.
Do any of these apply to you?
– Do you have any family members who have been diagnosed with a genetic condition?
– Are you pregnant or planning a family?
– Do you have previous personal history of a genetic condition?
– Are you interested in learning about your chance of having a genetic condition?
Our suite of diagnostic services includes toxicology, infectious diseases testing, hereditary cancer screening, hereditary cardiovascular, hereditary parkinson’s-alzheimer’s-dementia, hereditary diabetes and obesity, primary immunodeficiency response, pharmacogenomics, and carrier screening. Oxy-Gen Laboratory is a pioneer in scientific innovations and client partnerships.
Oxy-Gen offers a vast array of services, to get started; click the learn more button for additional information.
Covid-19 Testing
Flu Testing
Pharmacogenomics (PGx)
Cancer Screening (CGX)
Diabetes and Obesity
Cardiovascular Diseases
Immunodeficiency Screening
Parkinson’s- Alzheimer’s-Dementia
Carrier Screening
Toxicology
Oxy-Gen offers a vast array of services ranging from infectious disease panels, different genetic solutions, and even toxicology . To get started, click the learn more button for more in depth information.
Our genetic solutions range anywhere from hereditary cancer screening, hereditary cardiovascular, hereditary parkinson's-alzheimer's-dementia, hereditary diabetes and obesity, primary immunodeficiency response, pharmacogenomics, and carrier screening.
Our genetic solutions analyze a patient’s DNA for mutations/variants associated with carrier screening, oncology, and pharmacogenomics. We provide a comprehensive report indicating a patient’s potential susceptibility to various pathogenic variants associated with these conditions.
Our infectious diseases testing provides information about viral and bacterial pathogens in the system.
Our infectious diseases testing provides information about viral and bacterial pathogens in the patient’s system. This information helps guide a clinician’s treatment of a patient. In addition, this testing ensures the safe use of prescriptions and is designed to help doctors provide the highest level of care.
Our toxicology screening provides critical information and knowledge regarding use of various drugs. These results can be used by physicians, regulatory agencies, and even healthcare providers.
With an ongoing epidemic of drug misuse and abuse in America, it’s more important than ever for healthcare providers to monitor their patients as they treat them for pain, addiction, or chronic conditions. Oxy-Gen Laboratory's toxicology testing can help verify adherence, prevent diversion, and reduce the risks of addiction and adverse drug events. Oxy-Gen can also help the provider perform more thorough medication reconciliations.
Health testing has never been easier, faster, and more personalized. Browse the growing selection of tests available from Oxy-Gen Laboratory. You can view your cart or check the status of an order when you select my account below.
We accept self -pay and insurance. If you would like to pay with either one, please schedule a pre-counseling session with our professionals
Reasons for Hereditary Cancer Screening:
Our cancer screening test is a medical examination designed to detect early signs of cancer before symptoms develop. Early detection of cancer can improve treatment outcomes and increase the chances of a successful recovery.
The screening process for cancer typically involves a physical exam, medical history review, and laboratory tests. Depending on the type of cancer being screened for, additional imaging tests or biopsies may also be recommended.
Common cancer screening tests include mammography for breast cancer, colonoscopy for colorectal cancer, Pap smear for cervical cancer, and prostate-specific antigen (PSA) test for prostate cancer. Other types of cancer, such as lung cancer or skin cancer, may require different screening methods.
Do not add to bag and proceed to checkout without approval from an Oxy-Gen Laboratory representative.
Panel Information
Turnaround time: 2-4 weeks for results
Collection Method: Buccal Swab or Saliva
DISCLAIMER: The service and fee selected above covers your pre-consult or post-consult telehealth visit with one of our genetic counselors. Prior to ordering this test, you must have a medical necessity that will be determined by our Genetic Counselors.
Additionally, you may still be eligible for the test if you do not meet your insurance's medical necessity. Oxy-Gen Laboratory will follow up with you in this case to discuss our self-pay cost of the test.
Genes:
Multi-Cancer Panel (84 genes) AIP, ALK, APC, ATM, AXIN2, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, CASR, CDC73, CDH1, CDK4, CDKN1B, CDKN1C, CDKN2A, CEBPA, CHEK2, CTNNA1, DICER1, DIS3L2, EGFR, EPCAM, FH, FLCN, GATA2, GPC3, GREM1, HOXB13, HRAS, KIT, MAX, MEN1, MET, MITF, MLH1, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NTHL1, PALB2, PDGFRA, PHOX2B, PMS2, POLD1, POLE, POT1, PRKAR1A, PTCH1, PTEN, RAD50, RAD51C, RAD51D, RB1, RECQL4, RET, RUNX1, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, SMARCA4, SMARCB1, SMARCE1, STK11, SUFU, TERC, TERT, TMEM127, TP53, TSC1, TSC2, VHL, WRN, WT1
Common Hereditary Cancers Panel (47 genes) APC, ATM, AXIN2, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, CHEK2, CTNNA1, DICER1, EPCAM, GREM1, HOXB13, KIT, MEN1, MLH1, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NTHL1, PALB2, PDGFRA, PMS2, POLD1, POLE, PTEN, RAD50, RAD51C, RAD51D, SDHA, SDHB, SDHC, SDHD, SMAD4, SMARCA4, STK11, TP53, TSC1, TSC2, VHL
Breast Cancer Guidelines-Based Panel (11 genes) ATM, BARD1, BRCA1, BRCA2, CDH1, CHEK2, NF1, PALB2, PTEN, STK11, TP53
Oxy-Gen Breast Cancer Panel (26 genes) Primary Panel (13 genes) ATM, BARD1, BRCA1, BRCA2, CDH1, CHEK2, NF1, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53
Add-on Preliminary-evidence Genes for Breast Cancer (13 genes) ABRAXAS1, AKT1, BRIP1, FANCC, FANCM, MRE11, MUTYH, PIK3CA, RECQL, RINT1, SDHB, SDHD, XRCC2
Breast and Gyn Cancers Guidelines-Based Panel (19 genes) ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM, MLH1, MSH2, MSH6, NF1, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53
Breast and Gyn Cancers Panel (36 genes) Primary Panel (21 genes) ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, DICER1, EPCAM, MLH1, MSH2, MSH6, NF1, PALB2, PMS2, PTEN, RAD51C, RAD51D, SMARCA4, STK11, TP53
Add-on Preliminary-evidence Genes for Breast and Gyn Cancer (15 genes) ABRAXAS1, AKT1, CDC73, FANCC, FANCM, MRE11, MUTYH, NBN, PIK3CA, POLD1, RECQL, RINT1, SDHB, SDHD, XRCC2
Colorectal Cancer Guidelines-Based Primary Panel (20 genes) APC, AXIN2, BMPR1A, CDH1, CHEK2, EPCAM, GREM1, MLH1, MSH2, MSH3, MSH6, MUTYH, NTHL1, PMS2, POLD1, POLE, PTEN, SMAD4, STK11, TP53
Add-on Preliminary-evidence Genes for Colorectal Cancer (10 genes) ATM, BLM, BUB1B, CEP57, ENG, FLCN, GALNT12, MLH3, RNF43, RPS20
Prostate Cancer Panel (19 genes) Primary Panel (12 genes) ATM, BRCA1, BRCA2, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, NBN, PMS2, TP53
Add-on Preliminary-evidence Genes for Prostate Cancer (7 genes) ATR, BRIP1, FANCA, GEN1, PALB2, RAD51C, RAD51D
Nervous System/Brain Cancer Panel (42 genes) Primary Panel (29 genes) AIP, ALK, APC, DICER1, EPCAM, HRAS, LZTR1, MEN1, MLH1, MSH2, MSH6, NBN, NF1, NF2, PHOX2B, PMS2, POT1, PRKAR1A, PTCH1, PTEN, RB1, SMARCA4, SMARCB1, SMARCE1, SUFU, TP53, TSC1, TSC2, VHL
Add-on Preliminary-evidence Genes for Nervous System/Brain Cancer (5 genes) BAP1, EZH2, GPC3, KIF1B, PTCH2
Add-on Hereditary Paraganglioma-Pheochromocytoma Genes (8 genes) MAX, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, TMEM127
Melanoma Panel (12 genes) Primary Panel (9 genes) BAP1, BRCA2, CDK4, CDKN2A, MITF, POT1, PTEN, RB1, TP53
Add-on Preliminary-evidence Genes for Melanoma (3 genes) BRCA1, MC1R, TERT
Renal/Urinary Tract Cancers Panel (32 genes) Primary Panel (25 genes) BAP1, CDC73, CDKN1C, DICER1, DIS3L2, EPCAM, FH, FLCN, GPC3, MET, MLH1, MSH2, MSH6, PMS2, PTEN, REST, SDHB, SDHC, SMARCA4, SMARCB1, TP53, TSC1, TSC2, VHL, WT1
Add-on Preliminary-evidence Genes for Renal/Urinary Tract Cancers (7 genes) BUB1B, CEP57, CTR9, MITF, PALB2, SDHA, SDHD
Sarcoma Panel (44 genes) Primary Panel (29 genes) APC, BLM, CDKN1C, DICER1, EPCAM, EXT1, EXT2, FH, HRAS, KIT, MLH1, MSH2, MSH6, NBN, NF1, PDGFRA, PMS2, POT1, PRKAR1A, PTCH1, RB1, RECQL4, SDHA, SDHB, SDHC, SDHD, SUFU, TP53, WRN
Add-on Preliminary-evidence Genes for Sarcoma (4 genes) CDKN2A, PTCH2, TSC1, TSC2
Add-on Diamond-Blackfan Anemia Primary Genes (11 genes) GATA1, RPL11, RPL15, RPL26, RPL35A, RPL5, RPS10, RPS19, RPS24, RPS26, RPS7
Thyroid Cancer Panel (11 genes) Primary Panel (7 genes) APC, CHEK2, DICER1, PRKAR1A, PTEN, RET, TP53
Add-on Preliminary-evidence Genes for Thyroid Cancer (4 genes) MEN1, SDHB, SDHD, WRN
Prostate Cancer Panel 19 genes Primary Panel (12 genes) ATM, BRCA1, BRCA2, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, NBN, PMS2, TP53
Add-on Preliminary-evidence Genes for Prostate Cancer (7 genes) ATR, BRIP1, FANCA, GEN1, PALB2, RAD51C, RAD51D
We’re located in Norcross, Georgia. Our laboratory is in suite 100, take a look at the map for route directions.
©2016-2022 Oxy-Gen Laboratory LLC